University of Virginia
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 12
- Registration Number
- NCT04084171
- Locations
- 🇺🇸
Barbara Davis Center, University of Colorado, Aurora, Colorado, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures
- Conditions
- BleedingCoagulation Disorder, BloodProcedural ComplicationCirrhosis, Liver
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 1182
- Registration Number
- NCT04076605
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
- Conditions
- Puberty DisordersOvulation DisorderPolycystic Ovary Syndrome
- Interventions
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 24
- Registration Number
- NCT04075149
- Locations
- 🇺🇸
University of Virginia Center for Research in Reproduction, Charlottesville, Virginia, United States
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
- Conditions
- Estrogen Receptor-positive Breast CancerBreast Cancer
- Interventions
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- University of Virginia
- Registration Number
- NCT04038489
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Non-Contact Respiratory Rate Monitoring
- Conditions
- Hypoxia
- Interventions
- Device: Themography
- First Posted Date
- 2019-07-02
- Last Posted Date
- 2019-07-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 100
- Registration Number
- NCT04005911
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Interleukin-5 Receptor Expression in COPD
- Conditions
- COPD
- Interventions
- Procedure: Bronchoscopy
- First Posted Date
- 2019-06-13
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 20
- Registration Number
- NCT03984799
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Utilizing Helpline for Opioid Dependence Treatment
- Conditions
- Opioid Dependence
- Interventions
- Behavioral: Helpline
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 1000
- Registration Number
- NCT03969238
- Locations
- 🇺🇸
UVA Center for Leading Edge Addiction Research, Charlottesville, Virginia, United States
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency
- Conditions
- Immune Deficiency
- Interventions
- Biological: Salmonella typhi polysaccharide vaccine
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 37
- Registration Number
- NCT03968211
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
- Conditions
- B-cell Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 36
- Registration Number
- NCT03962465
- Locations
- 🇺🇸
University of Wisconsin, Madison, Wisconsin, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Drug: Oral combined hormonal contraceptives
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 88
- Registration Number
- NCT03905941
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States